Point of Care Nano-Technology, Inc. (PCNT)

USD 0.01

(0.0%)

Operating Expenses Summary of Point of Care Nano-Technology, Inc.

  • Point of Care Nano-Technology, Inc.'s latest annual operating expenses in 2023 was 73.41 Thousand USD , down -55.1% from previous year.
  • Point of Care Nano-Technology, Inc.'s latest quarterly operating expenses in 2023 FY was 73.41 Thousand USD , down -55.1% from previous quarter.
  • Point of Care Nano-Technology, Inc. reported a annual operating expenses of 163.51 Thousand USD in annual operating expenses 2022, up 2080.2% from previous year.
  • Point of Care Nano-Technology, Inc. reported a annual operating expenses of 7500.00 USD in annual operating expenses 2021, down -41.13% from previous year.
  • Point of Care Nano-Technology, Inc. reported a quarterly operating expenses of 25.86 Thousand USD for 2023 Q4, up 164.7% from previous quarter.
  • Point of Care Nano-Technology, Inc. reported a quarterly operating expenses of 9773.00 USD for 2023 Q3, down -25.71% from previous quarter.

Annual Operating Expenses Chart of Point of Care Nano-Technology, Inc. (2023 - 2010)

Historical Annual Operating Expenses of Point of Care Nano-Technology, Inc. (2023 - 2010)

Year Operating Expenses Operating Expenses Growth
2023 73.41 Thousand USD -55.1%
2022 163.51 Thousand USD 2080.2%
2021 7500.00 USD -41.13%
2020 12.74 Thousand USD 0.0%
2015 118.78 Million USD 64065.19%
2014 185.11 Thousand USD 57.09%
2013 117.84 Thousand USD -21.02%
2012 149.21 Thousand USD -74.15%
2011 577.29 Thousand USD 171.74%
2010 212.44 Thousand USD 0.0%

Peer Operating Expenses Comparison of Point of Care Nano-Technology, Inc.

Name Operating Expenses Operating Expenses Difference
America Great Health 661.23 Thousand USD 88.897%
Ampio Pharmaceuticals, Inc. 9.26 Million USD 99.208%
Aridis Pharmaceuticals, Inc. 29.99 Million USD 99.755%
Biora Therapeutics, Inc. 67.14 Million USD 99.891%
Bio-Path Holdings, Inc. 15.84 Million USD 99.537%
Better Therapeutics, Inc. 38.26 Million USD 99.808%
Calithera Biosciences, Inc. 40.68 Million USD 99.82%
Comera Life Sciences Holdings, Inc. 12.39 Million USD 99.408%
Gene Biotherapeutics, Inc. - USD -Infinity%
eFFECTOR Therapeutics, Inc. 33.84 Million USD 99.783%
Eloxx Pharmaceuticals, Inc. 34.41 Million USD 99.787%
Evelo Biosciences, Inc. 108.46 Million USD 99.932%
Evolutionary Genomics, Inc. 992.8 Thousand USD 92.605%
Finch Therapeutics Group, Inc. 32.58 Million USD 99.775%
Galera Therapeutics, Inc. 46.95 Million USD 99.844%
Innovation1 Biotech Inc. 1.21 Million USD 93.956%
Kiromic BioPharma, Inc. 19.93 Million USD 99.632%
Molecular Templates, Inc. 63.09 Million USD 99.884%
Navidea Biopharmaceuticals, Inc. 13.93 Million USD 99.473%
NexImmune, Inc. 28.16 Million USD 99.739%
Orgenesis Inc. 45.75 Million USD 99.84%
Panbela Therapeutics, Inc. 25.64 Million USD 99.714%
PaxMedica, Inc. Common Stock 16.14 Million USD 99.545%
Scopus BioPharma Inc. 11.71 Million USD 99.373%
Sorrento Therapeutics, Inc. 403.56 Million USD 99.982%
Statera Biopharma, Inc. 28.82 Million USD 99.745%
TRACON Pharmaceuticals, Inc. 18.92 Million USD 99.612%
Trevena, Inc. 38.41 Million USD 99.809%
Vaxxinity, Inc. 56.05 Million USD 99.869%
Vaccinex, Inc. 23.45 Million USD 99.687%
Vicapsys Life Sciences, Inc. 1.04 Million USD 92.988%
Viracta Therapeutics, Inc. 50.69 Million USD 99.855%
ZIVO Bioscience, Inc. 7.27 Million USD 98.991%